"Effects of long-term monotherapy with glimepiride vs glibenclamide on glycemic control and macrovascular events in Japanese Type 2 diabetic patients"
written by Hirohisa Onuma, Kouichi Inukai, Masaki Watanabe, Yoshikazu Sumitani, Toshio Hosaka, Hitoshi Ishida,
published by Journal of Diabetes Mellitus, Vol.4 No.1, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Pharmaceutical quality evaluation of different glimepiride brands marketed in Karachi (Pakistan): In pursuance to global issue of availability and affordability of …
2019
[2] Farmakoepidemiologija antidijabetičnih lekova i odnos pacijenata prema leku i lečenju dijabetes melitusa tipa 2 u Republici Srpskoj
2018
[3] Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide …
2016
[4] Development and validation of thin layer chromatography-densitometry method for determination of glimepiride in tablets
2016
[5] Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide …
2016
[6] Journal of Chemical and Pharmaceutical Research, 2016, 8 (3): 841-848
2016
[7] Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study
Cardiovascular diabetology, 2016
[8] Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes
Journal of Diabetes Mellitus, 2015
[9] Clinical Characteristics of Japanese Type 2 Diabetic Patients Responsive to Sitagliptin
Journal of Diabetes Mellitus, 2014
[10] Study of Biomarkers, Dietary, Lifestyle Practices and Knowledge Level of Diabetic Subjects Under Treatment
Thesis, 2014